Skip to main content
Clinical Trials/NCT00453947
NCT00453947
Completed
Phase 4

Non Invasive Positive Airway Pressure And Risk Of Myocardial Infarction In Acute Cardiogenic Pulmonary Edema: Continuous Positive Airway Pressure Vs Non Invasive Positive Pressure Ventilation

Ospedale S. Giovanni Bosco1 site in 1 country60 target enrollmentJuly 2002

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pulmonary Edema
Sponsor
Ospedale S. Giovanni Bosco
Enrollment
60
Locations
1
Primary Endpoint
The rate of Acute Myocardial Infarction
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

This randomized controlled trial is primarily aimed at assessing the rate of acute myocardial infarction with the two noninvasive ventilatory techniques, non-invasive intermittent positive pressure ventilation and non-invasive continuous positive airway pressure.

Detailed Description

Objective: To determine whether the application of non-invasive intermittent positive pressure ventilation (n-IPPV) increases the incidence of acute myocardial infarction (AMI) in patients with acute respiratory failure (ARF) secondary to acute cardiogenic pulmonary edema (ACPE), as opposed to non-invasive continuous positive airway pressure (n-CPAP). Background Both n-CPAP or n-IPPV are used to treat ACPE complicated by ARF. Two previous studies, however, report an increased rate of AMI associated with the use of n-IPPV. Methods: Fifty-two patients with severe ARF consequent to ACPE were randomized to receive n-CPAP (n=27) or n-IPPV (n=25), both associated with standard medical therapy. Cardiac markers, electrocardiogram and clinical-physiological parameters were monitored at study entry, after 30 and 60 minutes, and every 6 hours for the first two days.

Registry
clinicaltrials.gov
Start Date
July 2002
End Date
May 2005
Last Updated
19 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ospedale S. Giovanni Bosco

Eligibility Criteria

Inclusion Criteria

  • rapid onset of the symptoms
  • severe dyspnoea at rest
  • respiratory rate \> 30 breaths per minute
  • use of accessory respiratory muscles
  • oxygen saturation (SpO2) inferior to 90% with an inspiratory oxygen fraction of 60% via a Venturi mask
  • radiological findings of ACPE

Exclusion Criteria

  • acute ischemic heart disease (myocardial infarction, chest pain, ST elevation)
  • hemodynamic instability (i.e. systolic blood pressure \< 90 with dopamine or dobutamine infusion ≥ 5 mcgr/Kg/min) or life-threatening arrhythmias
  • need for immediate endotracheal intubation (respiratory arrest, bradypnea or gasping)
  • inability to protect the airways
  • impaired sensorium (i.e. unconsciousness or agitation)
  • inability to clear secretions
  • respiratory tract infection
  • recent oesophageal/gastric surgery
  • gastrointestinal bleeding
  • facial deformities

Outcomes

Primary Outcomes

The rate of Acute Myocardial Infarction

Secondary Outcomes

  • Rate of endotracheal intubation
  • Mortality
  • Time of recovery (i.e. duration of ventilatory assistance)
  • High Dependency Unit and hospital length of stay

Study Sites (1)

Loading locations...

Similar Trials